Search HealthyPeople.gov:

Home

About Healthy People

2020 Topics & Objectives

Data

Learn

Implement

Get Involved

Leading Health Indicators

Home > 2020 Topics & Objectives > Blood Disorders and Blood Safety

Blood Disorders and Blood SafetyNew

E-mail

Overview

Objectives

Interventions & Resources

National Snapshot

National Data

Expand All Objectives

Collapse All Objectives

Hemoglobinopathies

BDBS-1 (Developmental) Increase the proportion of persons with hemoglobinopathies who receive recommended vaccinations

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-2 (Developmental) Increase the proportion of persons with a diagnosis of hemoglobinopathies and their families who are referred for evaluation and treatment

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-3 (Developmental) Increase the proportion of persons with hemoglobinopathies who receive care in a patient or family-centered medical home

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-4 (Developmental) Increase the proportion of persons with a diagnosis of hemoglobinopathies who receive early and continuous screening for complications

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-5 (Developmental) Increase the proportion of persons with hemoglobinopathies who receive disease-modifying therapies

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-6 (Developmental) Increase the proportion of children with sickle cell disease who receive penicillin prophylaxis from 4 months to 5 years of age

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-7 (Developmental) Reduce hospitalizations due to preventable complications of sickle cell disease among children aged 9 years and under

Potential Data Source:

Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

More Information:

The HP2010 objective with the same definition was 16-21. View on DATA2010

BDBS-8 (Developmental) Increase the proportion of persons with a diagnosis of hemoglobinopathies who complete high school education or a General Education or Equivalency Diploma (GED) by 25 years of age

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-9 (Developmental) Increase the proportion of community-based organizations (CBOs) that provide outreach and awareness campaigns for hemoglobinopathies

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-10 (Developmental) Increase the proportion of hemoglobinopathy carriers who know their own carrier status

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

Bleeding and Clotting

BDBS-11 (Developmental) Increase the proportion of persons with bleeding disorders who receive recommended vaccinations.

Potential Data Source:	Universal Data Collection System (UDC), CDC, NCBBB

BDBS-12 Reduce the number of persons who develop venous thromboembolism (VTE)

Baseline:

54.3 persons per 10,000 population aged 18 years and older developed venous thromboembolism (VTE) in 2007 (age adjusted to the year 2000 standard population)

Target:

48.9 per 10,000 population

Target-Setting Method:

10 percent improvement

Data Sources:

National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS

More Information:

Data for this objective

BDBS-13 (Developmental) Reduce the number of adults who develop venous thromboembolism (VTE) during hospitalization

BDBS-13.1

(Developmental) Reduce venous thromboembolism (VTE) among adult medical inpatients

Potential Data Source:	National Hospital Discharge Survey (NHDS), CDC/NCHS

BDBS-13.2

(Developmental) Reduce venous thromboembolism (VTE) among adult surgical patients

Potential Data Source:	National Hospital Discharge Survey (NHDS), CDC/NCHS

BDBS-14 (Developmental) Increase the proportion of providers who refer women with symptoms suggestive of inherited bleeding disorders for diagnosis and treatment

Potential Data Source:	To be determined

BDBS-15 Increase the proportion of females with von Willebrand disease (vWD) who are timely and accurately diagnosed

Baseline:

28.4 percent of females with von Willebrand disease (vWD) were timely and accurately diagnosed in 2008

Target:

31.2 percent

Target-Setting Method:

10 percent improvement

Data Source:

Universal Data Collection System (UDC), CDC/NCBDDD

More Information:

Data for this objective

BDBS-16 Reduce the proportion of persons with hemophilia who develop reduced joint mobility due to bleeding into joints

Baseline:

82.9 percent of persons with hemophilia developed reduced joint mobility due to bleeding into joints in 2008

Target:

74.6 percent

Target-Setting Method:

10 percent improvement

Data Source:

Universal Data Collection System (UDC), CDC/NCBDDD

More Information:

Data for this objective

Blood Safety

BDBS-17 Increase the proportion of persons who donate blood

Baseline:

6.1 percent of the population aged 18 years and older reported donating blood within the past year in 2008 (age adjusted to the year 2000 standard population)

Target:

6.7 percent

Target-Setting Method:

10 percent improvement

Data Source:

National Health Interview Survey (NHIS), CDC/NCHS

More Information:

Data for this objective

The HP2010 objective with the same definition was 17-06. View on DATA2010

BDBS-18 (Developmental) Reduce the proportion of persons who develop adverse events resulting from the use of blood and blood products.

BDBS-18.1

(Developmental) Reduce the proportion of persons who develop adverse events due to transfusion-related acute lung injury (TRALI)

Potential Data Source:	National Blood Collection and Utilization Survey (NBCUS), HHS

BDBS-18.2

(Developmental) Reduce the proportion of persons who develop adverse events due to blood incompatibility

Potential Data Source:	National Blood Collection and Utilization Survey (NBCUS), HHS

BDBS-18.3

(Developmental) Reduce the proportion of persons who develop adverse events due to transfusion-transmitted infections

Potential Data Source:	National Blood Collection and Utilization Survey (NBCUS), HHS

BDBS-18.4

(Developmental) Reduce the proportion of persons who develop adverse events due to alloimmunization among persons with hemoglobinopathies

Potential Data Source:	Registry and Surveillance in Hemoglobinopathies (RuSH), NIH

BDBS-19 (Developmental) Reduce the proportion of persons who did not receive a transfusion due to a blood product shortage.

BDBS-19.1

(Developmental) Reduce the proportion of persons who did not receive red blood cells due to a blood product shortage

Potential Data Source:	National Blood Collection and Utilization Survey (NBCUS), HHS

BDBS-19.2

(Developmental) Reduce the proportion of persons who did not receive platelets due to a blood product shortage

Potential Data Source:	National Blood Collection and Utilization Survey (NBCUS), HHS

BDBS-19.3

(Developmental) Reduce the proportion of persons who did not receiveplasma derivatives due to a blood product shortage

Potential Data Source:	National Blood Collection and Utilization Survey (NBCUS), HHS

Expand All Objectives

Collapse All Objectives

X Close

This hyperlink will direct you to a non-governmental Website or application.

The appearance of external hyperlinks does not constitute endorsement by the United States Department of Health & Human Services (HHS) of the hyperlinked Website or application, or the information, products or services contained therein. Such hyperlinks are provided consistent with the intended purpose of this HHS Website. Visitors to the hyperlinked Website or application will be subject to the Website or application's privacy policies. These practices may be different than those of this HHS Website.

You will be redirected to: link